ABC logo

Abcam plc Stock Price

AIM:ABC Community·UK£2.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ABC Share Price Performance

UK£0
0.00 (0.00%)
UK£0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

ABC Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and good value.

3 Risks
2 Rewards

Abcam plc Key Details

UK£350.4m

Revenue

UK£89.9m

Cost of Revenue

UK£260.5m

Gross Profit

UK£253.2m

Other Expenses

UK£7.3m

Earnings

Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
0.032
74.34%
2.08%
16.4%
View Full Analysis

About ABC

Founded
1998
Employees
1682
CEO
Alan Hirzel
WebsiteView website
www.abcam.com

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Recent ABC News & Updates

Recent updates

No updates